Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors Further trials are warranted that evaluate adding a 10 mg dose of ...

Median overall survival (OS) and progression-free survival (PFS) in uterine carcinosarcoma (UCS) both improved with paclitaxel and carboplatin as compared with a standard-of-care regimen, a randomized ...

A dosage formula has been derived from a retrospective analysis of carboplatin pharmacokinetics in 18 patients with pretreatment glomerular filtration rates (GFR) in the range of 33 to 136 mL/min.

Please provide your email address to receive an email when new articles are posted on . Paclitaxel plus carboplatin demonstrated noninferiority to paclitaxel plus ifosfamide and should be a standard ...

Two major trials unveiled at the 2026 Society of Gynecologic Oncology meeting are reshaping ovarian cancer treatment. NRG-GY019 confirmed carboplatin-paclitaxel followed by letrozole as the standard ...

SAN ANTONIO — The addition of carboplatin to a standard neoadjuvant chemotherapy regimen significantly improves disease-free or event-free survival in patients with early-stage triple-negative breast ...

An ongoing shortage of the cancer treatment drugs carboplatin and cisplatin is forcing American doctors to delay or modify treatment plans – or in some cases, try alternative medications altogether.

Please provide your email address to receive an email when new articles are posted on . The addition of carboplatin to paclitaxel improved pathologic complete response and EFS with no increase in ...

The US Food and Drug Administration is working with drug manufacturers like the Chinese drugmaker Qilu Pharmaceutical to import the cancer medication cisplatin, as well as carboplatin, to boost supply ...

Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel. Single-agent carboplatin was less active and ...

Cancer patients, like those I treat in San Diego and thousands more across the country, are facing an alarming shortage of critical chemotherapy drugs, forcing oncologists to ration cancer treatment ...